LeonaBio
Share
We are a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration.
The mild-to-moderate stage of Alzheimer’s disease can be the most distressing and detrimental stage for patients, which is why disease-modifying treatments are pivotal to effectively tackle and potentially reverse neurodegeneration progression at this stage.
Hear from Dr. Anton Porsteinsson on the unmet need for new treatments to reduce patient burden below.
Listen to the full webinar on Alzheimer’s and the LIFT-AD clinical trial: https://bit.ly/3zrFW3O
Click here to claim your Sponsored Listing.
Category
Contact the business
Website
Address
18706 North Creek Parkway, Suite 104
Seattle, WA
98011
